Skip to main content

C.R. Bard Lawsuits Selected For Second Bellwether Trial

C.R. Bard Lawsuits Selected For Second Bellwether Trial

C.R. Bard Lawsuits Selected For Second Bellwether Trial

Introduction

In a case management order issued on June 28, Judge David Campbell presiding over the established Bard IVC filter MDL confirmed three lawsuits as the next bellwether trials. The trials are scheduled for September 2018, November 2018, and February 2019, respectively.

The first bellwether trial against Bard concluded with a $3.6 million verdict favoring the plaintiff while the jury sided with the defendant in the second bellwether trial on June 1, 2018. Lawsuits claim blood clot filters sold by C.R. Bard are defectively designed and tend to rupture and injure internal organs.

More than 3,500 Bard IVC lawsuits are filed against the manufacturer, which were centralized as part of a multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) on August 17, 2015, in the U.S. District Court District of Arizona. The outcome of these bellwether trials will be closely observed by other parties involved in the litigation for proceeding with eventual settlement negotiations.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!